A divergent role for estrogen receptor beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study

September 6th, 2008 by admin

IntroductionEstrogen organ alpha (ER-alpha) and progestogen organ (PgR) are consolidated predictors of salutation to hormonal therapy (HT). In contrast, lowercase aggregation is acquirable regarding the persona of oestrogen organ beta (ER-beta) in assorted boob cancer risk-groups aerated with assorted therapeutic regimens. In particular, there are no accumulation concerning ER-beta organisation within the new molecular boob cancer subtypes, luminal A (LA) and B (LB), HER2 (HS) and manifold perverse (TN).
Methods:
We conducted an empiric likely think evaluating, by immunohistochemistry, ER-beta countenance in 936 boob cancers. Associations with customary bio-pathological factors and with molecular subtypes were analyzed by binary proportionality psychotherapy (MCA), patch arrangement and abnormalcy tree (C&RT) psychotherapy and univariate and multivariate Cox abnormalcy analyses were practical to watch the effect of ER-beta countenance on disease liberated activity in the 728 patients with rank study up data.
Results:
ER-beta evenly distributes (55.5%) crossways the quaternary molecular boob cancer subtypes, confirming the demand of reciprocity between ER-beta and Hellenic prognosticators. However, the relationships among the bio-pathological factors, analysed by MCA, showed that ER-beta quality is settled in the line containing more battleful phenotypes much as HER2 and TN or ER-alpha/PgR/bcl2 perverse tumors. Kaplan-Meier curves and Cox abnormalcy psychotherapy identified ER-beta as a momentous diacritical bourgeois for disease liberated activity both in the node-negative, LA (p=0.02) subgroup, where it is prophetic of salutation to HT, and in the node-positive LB (p=0.04) assemble where, in connexion with PgR negativity, it conveys a higher venture of relapse.
Conclusions:
Our accumulation indicated that, in oppositeness to node-negative, in node-positive boob cancer patients, ER-beta quality appears to be a biomarker attendant to a more battleful clinical course. In this context, boost investigations are needed to meliorate set the persona of the assorted ER-beta isophorms.

Tags: , , , , ,

Posted in Cancer |

Related posts

Comments are closed.

Recent Posts

Categories

Archives:

Search: